Each year at YOGS, an alum of Yale Ob/Gyn is recognized for their contribution to the field. The 2026 honoree was David M. Gershenson, MD, professor of gynecology, oncology, and reproductive medicine at the University of Texas MD Anderson Cancer Center in Houston.
Since 1980, Gershenson’s research has focused on women with hereditary tumors and low-grade serous ovarian cancer. In 2004, he was part of the MD Anderson team that defined the binary histologic grading system for serous carcinoma, which was later adopted by the World Health Organization. He’s won multiple awards, including the 2026 Gynecologic Oncology Innovation Award from the Society of Gynecologic Oncology, the 2025 Pioneer of Progress Award from the STAAR Ovarian Cancer Foundation, and the 2024 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research from the Ovarian Cancer Research Alliance. He was also featured as a "Giant of Obstetrics and Gynecology" in the American Journal of Obstetrics and Gynecology.
Gershenson presented a special grand rounds talk to end the day of learning titled, “Three Giants, Interwoven Legacies: Johns Hopkins, MD Anderson and the Yale Influence.”